Exploring the link between lymphedema and myofascial pain in breast cancer patients
Myofascial Pain Syndrome in Patients With Breast Cancer-related Lymphedema
This study looks at how lymphedema affects pain and daily life for breast cancer patients to see if there's a connection between the two.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 110 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | Female |
| Sponsor | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey Academic / other |
| Locations | 1 site (İstanbul, Kadıköy) |
| Trial ID | NCT06012786 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the relationship between lymphedema and myofascial pain syndrome in breast cancer patients. It will assess whether the stage of lymphedema correlates with the frequency of myofascial pain and how lymphedema affects pain thresholds and trigger points. Additionally, the study will evaluate the impact of myofascial pain on upper extremity function and quality of life in these patients. A total of 110 participants who have undergone various breast cancer treatments will be included in this cross-sectional, single-centered, and single-blind study.
Who should consider this trial
Good fit: Ideal candidates are breast cancer patients aged 18-75 who have undergone specific surgical treatments or radiotherapy.
Not a fit: Patients with active infections, bilateral breast cancer, or uncontrolled psychiatric illnesses may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of pain management and improve quality of life for breast cancer patients with lymphedema.
How similar studies have performed: While the specific relationship between lymphedema and myofascial pain in breast cancer patients has not been extensively studied, related research in pain management and lymphedema has shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria : * Breast cancer patients aged between 18-75 who had undergone the treatments as mastectomy, breast conserving surgery, lymph node dissection, sentinele lymph node biopsy or radiotherapy providing a written consent to participate in the study Exclusion Criteria : * Patients who do not agree to participate the study * Patients who had signs of active infection as lymphangitis, cellulitis, fungus * Bilateral breast cancer patients * Uncontrolled Psychiatric illness
Where this trial is running
İstanbul, Kadıköy
- Sultan 2. Abdulhamid Han Training and Research Hospital — İstanbul, Kadıköy, Turkey (Recruiting)
Study contacts
- Principal investigator: Yeliz Bahar Özdemir
- Study coordinator: Özden Tömek, MD
- Email: ozden.tomek@gmail.com
- Phone: Turkey: +905343284941
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.